Form 4 for CPIX CUMBERLAND PHARMACEUTICALS INC
Accepted 2022-05-06 00:00:00 ET · period of report 2022-04-14 · accession 0001209191-22-027651 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-05-06 | 2022-04-14+ | CPIX | Young Caroline | Dir | P - Purchase | $2.61 | +214 | 15.9K | +1% | +$558.95 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-14 | P | A | 19 | $2.71 | 15,796 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022. |
| 2 | Common | Common Stock | 2022-04-18 | P | A | 19 | $2.63 | 15,815 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022. |
| 3 | Common | Common Stock | 2022-04-19 | P | A | 19 | $2.69 | 15,834 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022. |
| 4 | Common | Common Stock | 2022-04-20 | P | A | 19 | $2.74 | 15,853 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022. |
| 5 | Common | Common Stock | 2022-04-21 | P | A | 19 | $2.75 | 15,872 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022. |
| 6 | Common | Common Stock | 2022-04-29 | P | A | 20 | $2.44 | 15,991 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022. |
| 7 | Common | Common Stock | 2022-04-25 | P | A | 20 | $2.62 | 15,911 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022. |
| 8 | Common | Common Stock | 2022-04-26 | P | A | 20 | $2.53 | 15,931 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022. |
| 9 | Common | Common Stock | 2022-04-27 | P | A | 20 | $2.41 | 15,951 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022. |
| 10 | Common | Common Stock | 2022-04-28 | P | A | 20 | $2.51 | 15,971 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022. |
| 11 | Common | Common Stock | 2022-04-22 | P | A | 19 | $2.73 | 15,891 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022. |